Voluntary exercise induces structural remodeling in the hearts of dystrophin-deficient mice

Muscle and Nerve

Volumn 42, Issue 6, 2010, Pages 881-885

  Costas, Jeffrey M ^a   Nye, David J ^a   Henley, Jessica B ^a   Plochocki, Jeffrey H ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac remodeling; Dystrophin exercise; Fibrosis; Heart; Mdx

Indexed keywords

DYSTROPHIN;

ANIMAL TISSUE; ARTICLE; C57BL 10 MOUSE; CONTROLLED STUDY; EXERCISE; EXPLORATORY RESEARCH; FEMALE; HEART DILATATION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SITTING; VOLUNTARY MOVEMENT;

ANIMALS; FEMALE; FIBROSIS; HEART; MICE; MICE, INBRED MDX; MOTOR ACTIVITY; MUSCULAR DYSTROPHY, ANIMAL; MYOCARDIUM; PHYSICAL CONDITIONING, ANIMAL; STATISTICS, NONPARAMETRIC;

EID: 78649673370     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21783     Document Type: Article

References (39)

1. Blake D, Weir A, Newy S, Davies K. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002;82:291-329.
2. Hoffman EP, Brown RHP Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-928.
3. Grounds MD, Sorokin L, White J. Strength at the extracellular matrix-muscle interface. Scand J Med Sci Sports 2005;15:381-391.
4. Weller B, Karpati G, Carpenter S. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci 1990;100:9-13.
5. Frankel KA, Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976;7:375-386.
6. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990;26:271-277. (Pubitemid 20061348)
7. Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 2007;1772:229-237.
8. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002;12:926-929.
9. Cox GF, Kunkel LM. Dystrophies and heart disease. Curr Opin Cardiol 1997;12:329-343.
10. Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, Metzger JM. Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 2005;436:1025-1029.
11. Scott M, Hyde SA, Goddard C, Jones R, Dubowitz V. Effect of exercise in Duchenne muscular dystrophy. A controlled six-month feasibility study of the effects of two different regimes of exercises in children with Duchenne muscular dystrophy. Physiotherapy 1981;67:174-176.
12. Vignos PJ Jr, Watkins MP. The effect of exercise in muscular dystrophy. JAMA 1966;197:843-848.
13. Hayes A, Lynch GS, Williams DA. The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc R Soc Lond B Biol Sci 1987;253:19-25.
14. Sveen M-L, Jeppesen TD, Hauerslev A, Krag TO, Vissing J. Endurance training: an effective and safe treatment for patients with LGMD2I. Neurology 2007;68:59-61.
15. Grange RW, Call JA. Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc Sport Sci Rev 2007;35:12-17.
16. Bostick B, Yue Y, Long C, Duan D. Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res 2008;102:121-130.
17. Danialou G, Comtois AS, Dudley R, Karpati G, Vincent G, Des Rosiers C, et al. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J 2001;15:1655-1657.
18. Megeney LA, Kablar B, Perry RL, Ying C, May L, Rudnicki MA. Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc Natl Acad Sci USA 1999;96:220-225. (Pubitemid 29036080)
19. Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, Levin LS. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 2004;14:491-496.
20. Nakamura A, Yoshida K, Takeda S, Dohi N, Ikeda S. Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Lett 2002;520:18-24. (Pubitemid 34607266)
21. Townsend D, Yasuda S, Li S, Chamberlain JS, Metzger JM. Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. Mol Ther 2008;16:832-835.
22. Yue Y, Skimming JW, Liu M, Strawn T, Duan D. Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet 2004;13:1669-1675.
23. Dupont-Versteegden EE, McCarter RJ, Katz MS. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of Mdx mice. J Appl Physiol 1994;77:1736-1741.
24. Landisch RM, Kosir AM, Nelson SA, Baltgalvis KA, Lowe DA. Adaptive and nonadaptive responses to voluntary wheel running by mdx mice. Muscle Nerve 2008;38:1290-1303.
25. Hudecki MS, Pollina CM, Granchelli JA, Daly MK, Byrnes T, Wang JC, et al. Strength and endurance in the therapeutic evaluation of prednisolone-treated mdx mice. Res Commun Chem Pathol Pharmacol 1993;79:45-60.
26. Sandri M, Podhorska-Okolow M, Geromel V, Rizzi C, Arslan P, Franceschi C, et al. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 1997;56:45-57.
27. Hainsey TA, Senapati S, Kuhn DE, Rafael JA. Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul Disord 2003;13:294-302.
28. Spurney CF, Knoblach S, Pistilli EE, Nagaraju K, Martin GR, Hoffman EP. Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul Disord 2008;18:371-381.
29. Saito M, Kawai H, Akaike M, Adachi K, Nishida Y, Saito S. Cardiac dysfunction with Becker muscular dystrophy. Am Heart J 1996;132:642-647.
30. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 2007;17:290-296.
31. Williams IA, Allen DG. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol 2007;292:H846-855.
32. Wehling-Henricks M, Jordan MC, Roos KP, Deng B, Tidball JG. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet 2005;14:1921-1933.
33. Branco DM, Wolf CM, Sherwood M, Hammer PE, Kang PB, Berul CI. Cardiac electrophysiological characteristics of the mdx (5cv) mouse model of Duchenne muscular dystrophy. J Interv Card Electrophysiol 2007;20:1-7.
34. Carter GT, Wineinger MA, Walsh SA, Horasek SJ, Abresch RT, Fowler WM Jr. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 1995;5:323-332.
35. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B, et al. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 2003;304:453-463.
36. Stevenson, S, Rothery S, Cullen MJ, Severs NJ. Dystrophin is not a specific component of the cardiac costamere. Circ Res 1997;80:269-280.
37. 2+ signalling and reactive oxygen species-generating pathways. Cardiovasc Res 2008;77:766-773.
38. Kamogawa Y, Biro S, Maeda M, Setoguchi M, Hirakawa T, Yoshida H, Tei C. Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. Cardiovasc Res 2001;50:509-515.
39. Sveen ML, Jeppesen TD, Hauerslev S, Køber L, Krag TO, Vissing J. Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 2008;131:2824-2831.